Cargando…

EP1018: GASTROINTESTINAL BLEEDING DURING THE COVID-19 PANDEMIC: IMPACT ON PATIENT PRESENTATION AND OUTCOMES

Detalles Bibliográficos
Autores principales:	Kerbage, Anthony, Alrazim, Ayman, Tamim, Hani, Makki, Maha, Barada, Kassem, Shaib, Yasser H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212645/ http://dx.doi.org/10.1016/S0016-5085(22)62455-7

Ejemplares similares

Validation of the new ABC score for predicting 30-day mortality in gastrointestinal bleeding
por: Saade, Marie Christelle, et al.
Publicado: (2022)

Total esophageal food impaction in the era of the COVID-19 pandemic: a delayed presentation in a patient with Parkinson’s disease
por: Jabak, Suha J., et al.
Publicado: (2022)

Fr002 EFFECT OF THE COVID-19 PANDEMIC ON ACUTE GASTROINTESTINAL BLEEDING
por: Reddy, Sumana, et al.
Publicado: (2021)

EP1019: THE EFFECTS OF THE COVID-19 PANDEMIC ON PRESENTATIONS AND DIAGNOSIS OF UPPER GI AND HEPATOPANCREATICOBILIARY MALIGNANCIES
por: Carroll, Andrew, et al.
Publicado: (2022)

Mo1018: THE T-CELL RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS OFTEN DEFICIENT IN ANTIBODY-RESPONDERS, AND AUGMENTED BY ANTI-TNF THERAPY
por: Li, Dalin, et al.
Publicado: (2022)

Sa110 IMPACT OF COVID-19 PANDEMIC ON THE MANAGEMENT AND CLINICAL OUTCOMES OF PATIENTS ADMITTED WITH UPPER GASTROINTESTINAL BLEEDING
por: Manomaiwong, Ekawat, et al.
Publicado: (2021)

Fr012 THE OBSERVED RISK OF RECURRENT BLEEDING AND THROMBOEMBOLIC DISEASE IN COVID-19 PATIENTS WITH GASTROINTESTINAL BLEEDING.
por: Attah, Emmanuel O., et al.
Publicado: (2021)

EP1020: THE PREVALENCE OF GASTROINTESTINAL SYMPTOMS IN ACUTE COVID-19 INFECTION EVALUATED WITH A DIGITAL QUESTIONNAIRE
por: Malderen, Kathleen Van, et al.
Publicado: (2022)

Su254 REDUCED ENDOSCOPY UTILIZATION FOR UPPER GASTROINTESTINAL BLEEDING DURING COVID-19 PANDEMIC: A MULTICENTER RESEARCH NETWORK STUDY
por: Goyal, Hemant, et al.
Publicado: (2021)

Sa101 INCREASING THE LOW-RISK THRESHOLD FOR PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING DURING THE COVID-19 PANDEMIC: A PROSPECTIVE, MULTICENTRE, FEASIBILITY STUDY
por: Dunne, Philip, et al.
Publicado: (2021)

Sa1049: IMPACT OF THE NOVEL COVID-19 VIRUS ON OUTCOMES OF GASTROINTESTINAL BLEEDING: A MULTICENTER STUDY
por: Chouhan, Vijit, et al.
Publicado: (2022)

EP1017: CHANGING PERFORMANCE OF COLORECTAL CANCER SCREENING FOLLOWING A COVID-19 PANDEMIC IN KOREA
por: Kim, Hyun-Soo, et al.
Publicado: (2022)

EP1272: DIETARY LIPIDS FUEL METABOLIC ENTERITIS IN CROHN'S DISEASE
por: Schwärzler, Julian, et al.
Publicado: (2022)

EP1270: SEROCONVERSION IN INFLAMMATORY BOWEL DISEASE PATIENTS AFTER COVID-19 VACCINATION
por: Horvath, Miklos, et al.
Publicado: (2022)

113 COVID-19 PANDEMIC INCREASED HEALTHCARE UTILIZATION AMONG PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS
por: Gubatan, John Mark, et al.
Publicado: (2021)

Fr089 IMPACT OF COVID-19 ON PANDEMIC MAJOR GASTROENTEROLOGY PROCEDURES, VISITS, AND NEW DIAGNOSIS OF GASTROINTESTINAL CANCERS
por: Khan, Ahmad, et al.
Publicado: (2021)

Tu1108: INTERVAL CANCERS IN PATIENTS WITH HEREDITARY GASTROINTESTINAL SYNDROMES AFTER ONE YEAR OF THE SARS-COV-2 PANDEMIC
por: Barchi, Alberto, et al.
Publicado: (2022)

Su1071: PREVALENCE OF GASTROINTESTINAL SYMPTOMS AND RELATIONSHIP WITH POOR OUTCOMES AMONG PATIENTS WITH COVID-19 PRESENTING TO THE HOSPITAL: A NATIONAL DATABASE STUDY
por: Patil, Nikita, et al.
Publicado: (2022)

EP1021: CHANGES IN THE NEEDS OF IBD PATIENTS FOR TREATMENT BEFORE AND AFTER THE COIVD19 EPIDEMIC (ANALYSIS USING TWITTER DATA)
por: Fuchigami, Ayako
Publicado: (2022)

EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE
por: Shiga, Hisashi, et al.
Publicado: (2022)

EP1277: EFFICACY OF CARBON DIOXIDE INSUFFLATION DURING COLONOSCOPY FOR PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION -A RANDOMIZED TRIAL-
por: Otake, Yuriko, et al.
Publicado: (2022)

EP1273: PRACTICAL APPLICATION OF EVIDENCE-BASED DIETARY THERAPY INTO INFLAMMATORY BOWEL DISEASE CARE. PATIENT SATISFACTION, COMPLIANCE, AND EFFICACY. THE DELECTABLE PROGRAM.
por: Russell, Erin, et al.
Publicado: (2022)

EP1278: EFFICACY OF TOTAL ENTERAL NUTRITION COMBINED WITH AZATHIOPRINE IN MAINTAINING POSTOPERATIVE REMISSION IN CROHN'S DISEASE: A PARALLEL, RANDOMIZED CONTROLLED STUDY
por: Duan, Ming, et al.
Publicado: (2022)

EP1269: INTERIM ANALYSIS OF A MULTICENTER REGISTRY STUDY OF COVID-19 INFECTED PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN JAPAN (J-COSMOS).
por: Hayashi, Yuki, et al.
Publicado: (2022)

877: THE IMPACT OF THE CORONAVIRUS PANDEMIC AND GOVERNMENT LOCKDOWNS ON GASTROINTESTINAL DISEASE HOSPITALIZATIONS, INPATIENT MORTALITY, AND ENDOSCOPY UTILIZATION IN CALIFORNIA: A STATE-WIDE POPULATION-LEVEL ANALYSIS
por: Adekunle, Ayooluwatomiwa D., et al.
Publicado: (2022)

Fr005 SEVERE COVID-19 ASSOCIATED WITH INCREASED RISK OF GI BLEEDING DURING HOSPITALIZATION
por: Alvencar, Sujay, et al.
Publicado: (2021)

EP1271: UNPLANNED HOPSITAL ADMISSION AND EMERGENCY ATTENDANCE FOLLOWING TWO-DOSE OF BNT162B2 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED COHORT STUDY
por: Li, Xue, et al.
Publicado: (2022)

Fr492 SIGNIFICANTLY REDUCED MORTALITY IN COVID-19 PATIENTS WITH GASTROINTESTINAL MANIFESTATIONS
por: Livanos, Alexandra E., et al.
Publicado: (2021)

426 DETECTION OF SARS-COV-2 IN THE GASTROINTESTINAL TRACT AMONG PATIENTS WITH NEGATIVE NASOPHARYNGEAL COVID-19 TESTING PRIOR TO ENDOSCOPY: A PROSPECTIVE STUDY
por: Yang, Dennis, et al.
Publicado: (2021)

Mo1054: DIAGNOSTIC STRATEGIES FOR HELICOBACTER PYLORI IN PATIENTS WITH BLEEDING PEPTIC ULCERS UNDERGOING ENDOSCOPY: A COST-EFFECTIVENESS ANALYSIS
por: Artin, Michael G., et al.
Publicado: (2022)

782 PERSISTENT GASTROINTESTINAL SYMPTOMS AND CHRONIC FATIGUE AFTER SARS-COV-2 INFECTION.
por: Noviello, Daniele, et al.
Publicado: (2021)

Su083 PERSISTENCE OF GASTROINTESTINAL SYMPTOMS AFTER HOSPITALIZATION FOR COVID-19: PREVALENCE AND RISK FACTORS
por: Blackett, John W., et al.
Publicado: (2021)

Fr104 ASSOCIATION OF GASTROINTESTINAL SYMPTOMS WITH OUTCOMES IN COVID-19 HOSPITALIZATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
por: Mehta, Deep, et al.
Publicado: (2021)

Fr007 GASTROINTESTINAL MANIFESTATIONS OF COVID-19 ACROSS THE UNITED STATES: A MULTI-CENTER COHORT STUDY
por: Patel, Ankur, et al.
Publicado: (2021)

Fr004 GASTROINTESTINAL MANIFESTATIONS OF COVID-19 IN ICU AND NON-ICU PATIENTS: A MULTI-CENTER COHORT STUDY
por: Patel, Ankur, et al.
Publicado: (2021)

Fr101 COVID19 PATIENTS IN A TERTIARY HOSPITAL IN WASHINGTON DC: EFFECTS OF COMORBIDITIES AND GASTROINTESTINAL SYMPTOMS ON OUTCOME
por: Brim, Hassan, et al.
Publicado: (2021)

Fr498 NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COVID-19: DATA FROM AN INTERNATIONAL REGISTRY
por: Ungaro, Ryan C., et al.
Publicado: (2021)

787 TIVURON PROJECT: AN INTERNATIONAL MULTICENTER PROSPECTIVE COHORT STUDY EVALUATING THE GASTROINTESTINAL SYMPTOMS AND COMPLICATIONS OF COVID-19 IN HOSPITALIZED PATIENTS
por: Sánchez-Luna, Sergio A., et al.
Publicado: (2021)

Fr009 THE RELATIONSHIP BETWEEN ADIPOSITY/SARCOPENIA AND DEATH AMONG PATIENTS WITH COVID-19 DIFFERS BASED ON THE PRESENCE OF GASTROINTESTINAL SYMPTOMS
por: Nobel, Yael R., et al.
Publicado: (2021)

651: SARS-COV-2 IS DETECTED IN THE GASTROINTESTINAL TRACT OF ASYMPTOMATIC OUTPATIENTS USING ROUTINE ENDOSCOPY BUT POSES MINIMAL TRANSMISSION RISK
por: Gentry, Andrew B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3tujgn54qag3rdhseecucbq8e7